Aprea Therapeutics, Inc. — All Filings
405 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| EFFECT | — | 9999999995-26-000871 | Mar 19, 2026 | — |
| 424B3 | 424B3 | 0001104659-26-032181 | Mar 19, 2026 | — |
| S-3/A | S-3/A | 0001104659-26-029519 | Mar 17, 2026 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-26-028656 | Mar 16, 2026 | Mar 12, 2026 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-26-028653 | Mar 16, 2026 | Mar 12, 2026 |
| S-8 | FORM S-8 | 0001104659-26-028509 | Mar 16, 2026 | — |
| 10-K | 10-K | 0001104659-26-028068 | Mar 16, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001104659-26-028046 | Mar 16, 2026 | — |
| S-3 | S-3 | 0001104659-26-017755 | Feb 20, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-016797 | Feb 18, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015324 | Feb 13, 2026 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-26-009206 | Feb 2, 2026 | Jan 30, 2026 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-26-009203 | Feb 2, 2026 | Jan 30, 2026 |
| 8-K | FORM 8-K | 0001104659-26-007988 | Jan 29, 2026 | Jan 28, 2026 |
| SCHEDULE 13G/A | — | 0001493152-26-003971 | Jan 28, 2026 | — |
| 8-K | FORM 8-K | 0001104659-26-006267 | Jan 23, 2026 | — |
| 8-K | 8-K | 0001104659-26-002490 | Jan 9, 2026 | — |
| 424B3 | 424B3 | 0001104659-25-124943 | Dec 30, 2025 | — |
| EFFECT | — | 9999999995-25-003942 | Dec 29, 2025 | — |
| D | — | 0001781983-25-000003 | Dec 29, 2025 | — |
| S-3 | S-3 | 0001104659-25-123130 | Dec 19, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-120156 | Dec 11, 2025 | Dec 10, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-120155 | Dec 11, 2025 | Dec 10, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-120152 | Dec 11, 2025 | Dec 10, 2025 |
| 8-K | FORM 8-K | 0001104659-25-119680 | Dec 9, 2025 | Dec 8, 2025 |
| S-8 | FORM S-8 | 0001104659-25-119074 | Dec 8, 2025 | — |
| SCHEDULE 13G | — | 0000935836-25-000708 | Nov 17, 2025 | — |
| 10-Q | 10-Q | 0001104659-25-109867 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001104659-25-109860 | Nov 12, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-016261 | Nov 12, 2025 | — |
| 8-K | 8-K | 0001104659-25-102004 | Oct 24, 2025 | — |
| 8-K | 8-K | 0001104659-25-099534 | Oct 15, 2025 | — |
| 8-K | 8-K | 0001558370-25-011909 | Sep 8, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-011953 | Aug 13, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-011152 | Aug 12, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001558370-25-011149 | Aug 12, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-057823 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-057821 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-057818 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-057815 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-057813 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-057811 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-057809 | Jun 9, 2025 | Jun 5, 2025 |
| 8-K | FORM 8-K | 0001104659-25-057807 | Jun 9, 2025 | Jun 5, 2025 |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-057806 | Jun 9, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | — | 0000935836-25-000329 | May 14, 2025 | — |
| 10-Q | 10-Q | 0001558370-25-007667 | May 14, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001558370-25-007665 | May 14, 2025 | — |
| ARS | ARS | 0001558370-25-005148 | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0001558370-25-005145 | Apr 22, 2025 | — |